CIAM
RGNX icon

Caitong International Asset Management’s Regenxbio RGNX Stock Holding History

Caitong International Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8K Sell
1,321
-114
-8% -$946 ﹤0.01% 1044
2026
Q1 		$12K Buy
+1,435
New +$15.1K ﹤0.01% 1066
2025
Q4 		– Sell
-16
Closed -$154 – 2297
2025
Q3 		$154 Buy
+16
New +$142 ﹤0.01% 1700
2025
Q2 		– Sell
-185
Closed -$1.32K – 2400
2025
Q1 		$1.32K Buy
185
+120
+185% +$893 ﹤0.01% 1485
2024
Q4 		$502 Buy
+65
New +$610 ﹤0.01% 1462

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Caitong International Asset Management's RGNX Position: Q2 2026 in Review

Caitong International Asset Management reduced its Regenxbio (RGNX) stake by 7.9% in Q2 2026, selling an estimated $946 and leaving 1,321 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Caitong International Asset Management first reported a position in RGNX in Q4 2024 and has held it in 5 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Caitong International Asset Management held 1,321 shares of Regenxbio worth $15.8K as of Q2 2026.
  • Caitong International Asset Management sold 114 Regenxbio shares in Q2 2026, an estimated $946.
  • Regenxbio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1044 holding.
  • Caitong International Asset Management first reported a position in Regenxbio in Q4 2024 and has held it in 5 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.